{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:04:52Z","timestamp":1783911892488,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ad astra UCD","award":["R20439"],"award-info":[{"award-number":["R20439"]}]},{"name":"EU Marie Curie Doctoral Training Network \u2018Colomark\u2019","award":["HORIZON-MSCA-2021-DN-01"],"award-info":[{"award-number":["HORIZON-MSCA-2021-DN-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10620-025-09603-w","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:05:12Z","timestamp":1765454712000},"page":"2143-2155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Circulating Protein Biomarkers of Gut Barrier Integrity and Inflammation with Colorectal Adenomas and Colorectal Cancers"],"prefix":"10.1007","volume":"71","author":[{"given":"Harsha","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Sou\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"Li\u0161ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Genua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Holy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"9603_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 2019;14:89\u2013103. https:\/\/doi.org\/10.5114\/pg.2018.81072.","journal-title":"Prz Gastroenterol"},{"key":"9603_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.tem.2022.01.002","volume":"33","author":"J Martel","year":"2022","unstructured":"Martel J, Chang S-H, Ko Y-F, Hwang T-L, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab 2022;33:247\u2013265. https:\/\/doi.org\/10.1016\/j.tem.2022.01.002.","journal-title":"Trends Endocrinol Metab"},{"key":"9603_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626349","volume":"11","author":"F Genua","year":"2021","unstructured":"Genua F, Raghunathan V, Jenab M, Gallagher WM, Hughes DJ. The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development. Front Oncol 2021;11:626349. https:\/\/doi.org\/10.3389\/fonc.2021.626349.","journal-title":"Front Oncol"},{"key":"9603_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100829","volume":"32","author":"EA Ivleva","year":"2022","unstructured":"Ivleva EA, Grivennikov SI. Microbiota-driven mechanisms at different stages of cancer development. Neoplasia 2022;32:100829. https:\/\/doi.org\/10.1016\/j.neo.2022.100829.","journal-title":"Neoplasia"},{"key":"9603_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681810","volume":"12","author":"L Meng","year":"2021","unstructured":"Meng L, Song Z, Liu A, Dahmen U, Yang X, Fang H. Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases. Metabolic Disorders and Cancers. Front Immunol. 2021;12:681810. https:\/\/doi.org\/10.3389\/fimmu.2021.681810.","journal-title":"Metabolic Disorders and Cancers. Front Immunol."},{"key":"9603_CR6","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.bpj.2014.04.016","volume":"106","author":"PG Adams","year":"2014","unstructured":"Adams PG, Lamoureux L, Swingle KL, Mukundan H, Monta\u00f1o GA. Lipopolysaccharide-Induced Dynamic Lipid Membrane Reorganization: Tubules, Perforations, and Stacks. Biophys J 2014;106:2395\u20132407. https:\/\/doi.org\/10.1016\/j.bpj.2014.04.016.","journal-title":"Biophys J"},{"key":"9603_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/1055-9965.EPI-15-0798","volume":"25","author":"SY Kong","year":"2016","unstructured":"Kong SY, Tran HQ, Gewirtz AT et al. Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Cancer Epidemiol Biomarkers Prev 2016;25:291\u2013301. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0798.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9603_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/1574-6941.12250","volume":"87","author":"S Xiao","year":"2014","unstructured":"Xiao S, Zhao L. Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol 2014;87:303\u2013314. https:\/\/doi.org\/10.1111\/1574-6941.12250.","journal-title":"FEMS Microbiol Ecol"},{"key":"9603_CR9","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3748\/wjg.v17.i18.2326","volume":"17","author":"R Chen","year":"2011","unstructured":"Chen R, Luo F-K, Wang Y-L, Tang J-L, Liu Y-S. LBP and CD14 polymorphisms correlate with increased colorectal carcinoma risk in Han Chinese. World J Gastroenterol 2011;17:2326\u20132331. https:\/\/doi.org\/10.3748\/wjg.v17.i18.2326.","journal-title":"World J Gastroenterol"},{"key":"9603_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2013.05.033","volume":"337","author":"M Krzystek-Korpacka","year":"2013","unstructured":"Krzystek-Korpacka M, Diakowska D, Kapturkiewicz B, B\u0119benek M, Gamian A. Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance. Cancer Letters 2013;337:107\u2013114. https:\/\/doi.org\/10.1016\/j.canlet.2013.05.033.","journal-title":"Cancer Letters"},{"key":"9603_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12885-022-09440-4","volume":"22","author":"N Blad","year":"2022","unstructured":"Blad N, Palmqvist R, Karling P. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study. BMC Cancer 2022;22:315. https:\/\/doi.org\/10.1186\/s12885-022-09440-4.","journal-title":"BMC Cancer"},{"key":"9603_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/hrt.78.3.273","volume":"78","author":"MA Mendall","year":"1997","unstructured":"Mendall MA, Patel P, Asante M et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273\u2013277. https:\/\/doi.org\/10.1136\/hrt.78.3.273.","journal-title":"Heart"},{"key":"9603_CR13","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.4049\/jimmunol.171.11.6164","volume":"171","author":"M Bruewer","year":"2003","unstructured":"Bruewer M, Luegering A, Kucharzik T et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms1. The Journal of Immunology 2003;171:6164\u20136172. https:\/\/doi.org\/10.4049\/jimmunol.171.11.6164.","journal-title":"The Journal of Immunology"},{"key":"9603_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2214\/AJR.06.0764","volume":"188","author":"DH Kim","year":"2007","unstructured":"Kim DH, Pickhardt PJ, Taylor AJ. Characteristics of advanced adenomas detected at CT colonographic screening: implications for appropriate polyp size thresholds for polypectomy versus surveillance. AJR Am J Roentgenol 2007;188:940\u2013944. https:\/\/doi.org\/10.2214\/AJR.06.0764.","journal-title":"AJR Am J Roentgenol"},{"key":"9603_CR15","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1056\/NEJMoa1309086","volume":"370","author":"DA Corley","year":"2014","unstructured":"Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298\u20131306. https:\/\/doi.org\/10.1056\/NEJMoa1309086.","journal-title":"N Engl J Med"},{"key":"9603_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/biomedicines10010083","volume":"10","author":"P Portincasa","year":"2021","unstructured":"Portincasa P, Bonfrate L, Khalil M et al. Intestinal barrier and permeability in health. Obesity and NAFLD. Biomedicines 2021;10:83. https:\/\/doi.org\/10.3390\/biomedicines10010083.","journal-title":"Obesity and NAFLD. Biomedicines"},{"key":"9603_CR17","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.micinf.2004.08.015","volume":"6","author":"KA Fitzgerald","year":"2004","unstructured":"Fitzgerald KA, Rowe DC, Golenbock DT. Endotoxin recognition and signal transduction by the TLR4\/MD2-complex. Microbes and Infection 2004;6:1361\u20131367. https:\/\/doi.org\/10.1016\/j.micinf.2004.08.015.","journal-title":"Microbes and Infection"},{"key":"9603_CR18","first-page":"3834","volume":"18","author":"H-Y Huang","year":"2014","unstructured":"Huang H-Y, Zhang Z-J, Cao C-B et al. The TLR4\/NF-\u03baB signaling pathway mediates the growth of colon cancer. Eur Rev Med Pharmacol Sci 2014;18:3834\u20133843.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9603_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s40001-024-02168-w","volume":"29","author":"A Bahrami","year":"2024","unstructured":"Bahrami A, Khalaji A, Bahri Najafi M et al. NF-\u03baB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets. Eur J Med Res 2024;29:610. https:\/\/doi.org\/10.1186\/s40001-024-02168-w.","journal-title":"Eur J Med Res"},{"key":"9603_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102982","volume":"9","author":"T Gwenzi","year":"2024","unstructured":"Gwenzi T, Schrotz-King P, Anker SC, Sch\u00f6ttker B, Hoffmeister M, Brenner H. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts. ESMO Open 2024;9:102982. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102982.","journal-title":"ESMO Open"},{"key":"9603_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10654-014-9901-8","volume":"29","author":"K Aleksandrova","year":"2014","unstructured":"Aleksandrova K, Jenab M, Bueno-de-Mesquita HB et al. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol 2014;29:261\u2013275. https:\/\/doi.org\/10.1007\/s10654-014-9901-8.","journal-title":"Eur J Epidemiol"},{"key":"9603_CR22","doi-asserted-by":"publisher","unstructured":"DeMoulin D, Cai H, Cai Q, Zheng W, Shu X-O. Assessment of adipokine and inflammation biomarkers with cancer risk among Chinese men: A prospective cohort study. Cancer Epidemiol Biomarkers Prev. 34:OF1-OF13. https:\/\/doi.org\/10.1158\/1055-9965.EPI-25-0342","DOI":"10.1158\/1055-9965.EPI-25-0342"},{"key":"9603_CR23","unstructured":"Pathirana WGW, Chubb SP, Gillett MJ, Vasikaran SD. Faecal Calprotectin. Clin Biochem Rev 39:77\u201390."},{"key":"9603_CR24","doi-asserted-by":"publisher","unstructured":"Ockner RK, Manning JA. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J Clin Invest 54:326\u2013338. https:\/\/doi.org\/10.1172\/JCI107768","DOI":"10.1172\/JCI107768"},{"key":"9603_CR25","doi-asserted-by":"publisher","unstructured":"Lau E, Marques C, Pestana D, Santoalha M, Carvalho D, Freitas P, et al. The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. Nutr Metab (Lond) 13:31. https:\/\/doi.org\/10.1186\/s12986-016-0089-7","DOI":"10.1186\/s12986-016-0089-7"},{"key":"9603_CR26","doi-asserted-by":"publisher","unstructured":"Logan M, MacKinder M, Clark CM, Kountouri A, Jere M, Ijaz UZ, et al. Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn\u2019s disease. BMC Gastroenterol 22:260. https:\/\/doi.org\/10.1186\/s12876-022-02334-6","DOI":"10.1186\/s12876-022-02334-6"},{"key":"9603_CR27","doi-asserted-by":"publisher","unstructured":"Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regulatory Peptides 147:25\u201328. https:\/\/doi.org\/10.1016\/j.regpep.2007.12.002","DOI":"10.1016\/j.regpep.2007.12.002"},{"key":"9603_CR28","doi-asserted-by":"publisher","unstructured":"Maryam S, Krukiewicz K, Haq IU, Khan AA, Yahya G, Cavalu S. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. J Clin Med 12:3127. https:\/\/doi.org\/10.3390\/jcm12093127","DOI":"10.3390\/jcm12093127"},{"key":"9603_CR29","doi-asserted-by":"publisher","unstructured":"Wang J, Wang Y, Wang S, Cai J, Shi J, Sui X, et al. Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer. Oncotarget 6:42825\u201342837. https:\/\/doi.org\/10.18632\/oncotarget.5739","DOI":"10.18632\/oncotarget.5739"},{"key":"9603_CR30","doi-asserted-by":"publisher","unstructured":"Omran TA, Mads\u00f8 IL, S\u00e6ther PC, Bemanian V, Tunsj\u00f8 HS. Selection of optimal extraction and RT-PCR protocols for stool RNA detection of colorectal cancer associated immune genes. Sci Rep 14:27468. https:\/\/doi.org\/10.1038\/s41598-024-78680-0","DOI":"10.1038\/s41598-024-78680-0"},{"key":"9603_CR31","doi-asserted-by":"publisher","unstructured":"Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker. American Journal of Epidemiology 159:882\u2013890. https:\/\/doi.org\/10.1093\/aje\/kwh101","DOI":"10.1093\/aje\/kwh101"},{"key":"9603_CR32","doi-asserted-by":"publisher","unstructured":"Yoon JY, Cha JM, Jeen YT, Diseases (KASID) MPC of KA for the S of I, Endoscopy (KSGE) QIC of KS of G. Quality is the Key for Emerging Issues of Population-Based Colonoscopy Screening. Clin Endosc 51:50\u201355. https:\/\/doi.org\/10.4166\/kjg.2018.71.1.3","DOI":"10.4166\/kjg.2018.71.1.3"},{"key":"9603_CR33","doi-asserted-by":"publisher","unstructured":"van Lanschot MCJ, Carvalho B, Coup\u00e9 VMH, van Engeland M, Dekker E, Meijer GA. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study. BMC Cancer 17:116. https:\/\/doi.org\/10.1186\/s12885-017-3078-y","DOI":"10.1186\/s12885-017-3078-y"},{"key":"9603_CR34","doi-asserted-by":"publisher","unstructured":"Ross FA, Park JH, Mansouri D, Combet E, Horgan PG, McMillan DC, et al. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis. BMC Gastroenterology 22:176. https:\/\/doi.org\/10.1186\/s12876-022-02220-1","DOI":"10.1186\/s12876-022-02220-1"},{"key":"9603_CR35","doi-asserted-by":"publisher","unstructured":"Seethaler B, Basrai M, Neyrinck AM, Nazare J-A, Walter J, Delzenne NM, et al. Biomarkers for assessment of intestinal permeability in clinical practice. Am J Physiol Gastrointest Liver Physiol 321:G11\u2013G17. https:\/\/doi.org\/10.1152\/ajpgi.00113.2021","DOI":"10.1152\/ajpgi.00113.2021"},{"key":"9603_CR36","doi-asserted-by":"publisher","unstructured":"Xu J, Ye Y, Zhang H, Szmitkowski M, M\u00e4kinen M, Li P, et al. Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer. Medicine (Baltimore) 95:e2502. https:\/\/doi.org\/10.1097\/MD.0000000000002502","DOI":"10.1097\/MD.0000000000002502"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09603-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:26:32Z","timestamp":1783909592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9603"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09603-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all subjects involved in the study, and all patient samples were pseudonymized to protect participant identity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Study approvals for the Irish cohort were provided by the St. James\u2019s Hospital and Federated Dublin Voluntary Hospitals Joint Research Ethics Committee, reference 2007\u201337-17, and the St Vincent\u2019s Healthcare Group Ethics and Medical Research Committee (protocol no.18 for study \u2018Identification of genetic and molecular factors associated with bowel diseases, treatment sensitivity and resistance\u2019). The approval for Czech cohorts was given by the Institutional Review Boards of the Faculty of Medicine in Pilsen, Charles University (approval no. EK-VP\/42\/0\/2018) and the National Institute of Public Health in Prague (reference no. SZU\/01979\/2022).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}]}}